| ASSET | YEAR | % RETURN |
|---|---|---|
GeneDx (WGS) | 2024 | 2,880% |
Sezzle Inc Common Stock (SEZL) | 2024 | 2,109.52% |
Nuscale Power (SMR) | 2024 | 766.05% |
Avidity Biosciences (RNA) | 2024 | 400.33% |
ADMA Biologics (ADMA) | 2024 | 377.11% |
Janux Therapeutics (JANX) | 2024 | 357.12% |
Lumen Technologies (LUMN) | 2024 | 334.64% |
Ast Spacemobile (ASTS) | 2024 | 313.14% |
PureCycle Technologies (PCTTW) | 2024 | 310.3% |
Sweetgreen (SG) | 2024 | 296.84% |
SoundHound AI (SOUN) | 2024 | 277% |
Nextnav Acquisition (NN) | 2024 | 265.16% |
BBVA Banco Frances SA ADR (BBAR) | 2024 | 263.23% |
Hims Hers Health (HIMS) | 2024 | 256.25% |
IES (IESC) | 2024 | 253.04% |
Grupo Financiero Galicia SA ADR (GGAL) | 2024 | 248.86% |
Argan (AGX) | 2024 | 242.17% |
United States Lime & Minerals (USLM) | 2024 | 231.13% |
Powell Industries (POWL) | 2024 | 224.21% |
Longboard Pharmaceuticals (LBPH) | 2024 | 224.19% |
Banco Macro SA B ADR (BMA) | 2024 | 220.91% |
Purecycle Technologies (PCT) | 2024 | 219.8% |
Lemonade (LMND) | 2024 | 218.88% |
Rush Street Interactive (RSI) | 2024 | 212.93% |
Vera Therapeutics (VERA) | 2024 | 210.99% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
